Kyoto University in Japan has partnered with information technology firm Fujitsu to establish a joint research project to use artificial intelligence (AI) within medicine.

Established at the Kyoto University Graduate School of Medicine, the Department of Medical Intelligent Systems project will run until March 2020.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

As part of the project, Kyoto University Hospital’s medical information will be used along with Fujitsu’s advanced AI technology called Fujitsu Human Centric AI Zinrai to accelerate research and development (R&D) for advanced, next-generation medicine.

The university’s physicians and bioinformatics researchers will work together with Fujitsu’s AI engineers to leverage the database platform for analysis of large medical data to discover new diagnostic methods and treatments.

“The organisations plan to utilise the findings of the project and the AI platform for future advances in medicine.”

Medical information to be used during the project includes data collected from the University Hospital’s electronic medical records, data from cancer patients recorded in the Kyoto University Cancer Treatment Support Database System, and cohort data.

This data will be initially preprocessed with natural language processing and then an environment for analysis will be created.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Machine learning will be subsequently used to extract the common characteristics for diseases and create models that will support new diagnostic approaches such as the identification of specific disease characteristics from medical images, and discovery of next-generation drugs.

The organisations plan to utilise the findings of the project and the AI platform for future advances in medicine. Fujitsu expects that additional research on the platform could enable use in other fields such as manufacturing and finance.